loader2
Partner With Us NRI

Company details

1,768.70
1,880.00
1,113.00
2,174.90
6M Return 29.70%
1Y Return 38.03%
Mkt Cap.(Cr) 3,645.62
Volume 3,410
Div Yield 0.08%
OI
-
OI Chg %
-
Volume 3,410

Open Free Demat Account Online with ICICIDIRECT

SWOT

  • swot

  • technicals

  • deals

  • shareholding


EMA SMA

Delivery and volume

Our Research View

Trading recommendation

Data not found

Investment recommendation

CRAMS likely to witness strong growth ahead...

Call Date

04 May 2022

Entry Price

1,875.00

Target Price

2,215.00

Duration

12 Month

Financials

  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio

Sales(Cr.)

Operating Profit(Cr.)

Profit after Tax(Cr.)

Equity

Reserves and Surplus

Debt

Sales

Operating Profit

Profit after tax

PE

Debt/Equity

P BV

INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: 309.18 Cr FV: 10.00
Period MF Net Purchase / (sold) FII Net
LAST 1M 20,712.90 -49,208.14
LAST 3M 72,514.10 -86,871.53
LAST 6M 139,386.11 -217,992.74
LAST 12M 232,044.22 -250,830.89

Information

  • About Company
  • Company Info
  • Listing Info
39.73
65.29%
202.3199
20.43%
21.17%
Description
  • Astec LifeSciences Ltd is a producer of agrochemicals and pharmaceutical intermediates. The company manufactures a wide range of Agrochemical active ingredients and pharmaceutical intermediates. They are having manufacturing facilities located at two locations in Maharashtra, India comprising of three units viz. one unit at Dombivli, Maharashtra and two units at Mahad, Maharashtra (Unit 1 and Unit 2). They are exporting their products to East Asia, Europe, Middle East, and USA. The business of the company comprises of the two major segments, namely Agrochemicals and Pharmaceuticals. Under the Agrochemical segment, the company manufactures active ingredients, intermediates and formulations. Active ingredients are sold to crop protection formulators. Intermediates are supplied to technical grade product manufacturers. Formulations are sold in bulk quantities to companies engaged in retail marketing. Under the Pharmaceutical segment, the company carries out manufacturing of intermediates which are supplied to Active Pharma Ingredients (API) manufacturers. Astec LifeSciences Ltd was incorporated on January 25, 1994 as a private limited company with the name Urshila Traders Pvt Ltd. The company was originally promoted by Reena Bagai and Avita Fernandes. Their shareholding was purchased by Ashok Hiremath and Pratap Garud on February 11, 1994. In August 19, 1994, the name of the company was changed from Urshila Traders Pvt Ltd to Astec Chemicals Pvt Ltd. In August 1994, the company started their first manufacturing unit by acquiring a sick unit in Dombivli, Maharashtra having an installed capacity of 120 MT for the manufacture of Dicap, a pharmaceutical intermediate. In May 2001, they were awarded ISO 9002 Certification by International Standards Certification Pty Limited, Australia. In February 18, 2002, the company entered into an agreement with Behram Chemicals Pvt Ltd with a view to expand their operations for using and operating their manufacturing facilities located at Mahad in Maharashtra. Behram Chemicals Pvt Ltd was engaged in manufacture of chemicals and pesticides with installed capacity of 130 MT. During the year 2003-04, the company expanded the total installed capacity of their units (Dombivli and Mahad) from 250 MT to 500 MT. In the year 2004, they acquired a plot of land located at Mahad, Maharashtra. In May 2005, they set up a new manufacturing facility as an Export Oriented Unit (as Unit 2), which is adjacent to Unit 1 with an installed capacity of 1000 MT. With the commissioning of Unit 2, the company`s total installed capacity increased to 1500 MT. In March 2006, the name of the company was changed from Astec Chemicals Pvt Ltd to Astec LifeSciences Pvt Ltd. In April 2006, the company was converted into public limited company and the name was changed to Astec LifeSciences Ltd. During the year 2006-07, the company further expanded their total capacities to 2000 MT. In January 2007, they established Astec Europe in Tournai, Belgium. During the year 2007-08, the company increased the production capacity of Agro & Pharma Intermediates by 500 MT to 2500 MT In April 2007, Behram Chemicals Pvt Ltd became the subsidiary of the company by the acquisition of 65.63% equity by the company vide Share Purchase Agreement. During the year 2008-09, the company increased the production capacity of Agro & Pharma Intermediates by 300 MT to 2800 MT. They established a relationship with a major multinational for supply of one of our products into the global supply chain. During the year 2009-10, the company increased the production capacity of Agro & Pharma Intermediates by 350 MT to 3150 MT. They also introduced new measures to improve EHS performance. In December 2009, the company has bagged orders worth Rs 7 crore from Syngenta India and Nufarm, which are amongst the world`s top ten largest agrochemical manufacturing companies. In June 2010, the company entered into a long term mutually exclusive confidential contract to supply an herbicide to a multinational agrochemical major. In August 2010, the company acquired land in MIDC Mahad area admeasuring 40000 sq mtrs with a view to set up additional manufacturing facilities on the new site. In August 27, 2010, the company`s Chairman & Managing Director, Ashok V Hiremath was awarded Prestigious `Business Excellence` Award by the `Indo-Thai Entrepreneurs Summit` Bangkok, Thailand for his outstanding contribution towards progress and development of Indian Economy and Society. The company will introduce 3 new products during the financial year 2010-11. They are also investing in boosting their R&D capabilities.

Read More

Registered Address

GodrejOne 3rd Fl Pirojshanagar, Vikhroli (E) Eastern Exp Highw, Mumbai, Maharashtra, 400079

Tel : 91-22-25188010
Email : astecinfo:godrejastec.com
Website : http://www.astecls.com

Registrar

Bigshare Services Pvt Ltd

AGM Date (Month) : Jul
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 533138
NSE Code : ASTEC
Book Closure Date (Month) :
BSE Group : A
ISIN : INE563J01010

ICICIdirect Astec Lifesciences Ltd FAQ

You can buy Astec Lifesciences Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Astec Lifesciences Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Jul 01, 2022 04:01 PM the closing price of Astec Lifesciences Ltd was ₹ 1,860.20.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Jul 01, 2022 04:01 PM, the market cap of Astec Lifesciences Ltd stood at ₹ 3,645.62.
The latest PE ratio of Astec Lifesciences Ltd as of Jul 01, 2022 04:01 PM is 39.73
The latest PB ratio of Astec Lifesciences Ltd as of Jul 01, 2022 04:01 PM is 0.11
The 52-week high of Astec Lifesciences Ltd is ₹ 2,174.90 while the 52-week low is ₹ 1,113.00 .
According to analyst recommendations, Astec Lifesciences Ltd has a “Buy” rating for the long term.

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote

CLOSE